[Cómo manejo a pacientes con leucemia linfoblástica aguda de células B recidivantes/refractarias tratados con células

Y Wang1

  • 1State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Haihe Laboratory of Cell Ecosystem, Institute of Hematology & Blood Diseases Hospital, Chinese Academy of Medical Sciences & Peking Union Medical College, Tianjin 300020, China; Tianjin Institutes of Health Science, Tianjin 301600, China.

Resumen

No abstract available in PubMed .